Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 351125, a CCR5 antagonist

By Ghosal A.   Chowdhury S. K.   Gupta S.   Yuan Y.   Iannucci R.   Zhang H.   Zbaida S.   Patrick J. E.   Alton K. B.  

Xenobiotica, Vol. 35, Iss. 5, 2005-05 ,pp. : 405-417

Informa Healthcare

Access to resources Recommend Favorite

Disposition of a novel and potent α_vβ₃ antagonist in animals, and extrapolation to man

By Prueksaritanont T.   Fernandez-Metzler C.   Meng Y.   Barrish A.   Halczenko W.   Rodan S. B.   Hutchinson J. H.   Duggan M. E.   Lin J. H.  

Xenobiotica, Vol. 34, Iss. 1, 2004-01 ,pp. : 103-115

Informa Healthcare

Access to resources Recommend Favorite

Renal elimination of a novel and potent  v β 3 integrin antagonist in animals

By Prueksaritanont T.   Hochman J. H.   Meng Y.   Pudvah N. T.   Barrish A.   Ma B.   Yamazaki M.   Fernandez-metzler C.   Lin J. H.  

Xenobiotica, Vol. 34, Iss. 11-12, 2004-11 ,pp. : 1059-1074

Informa Healthcare

Access to resources Recommend Favorite

Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes

By Nakashima A.   Kawashita H.   Masuda N.   Saxer C.   Niina M.   Nagae Y.   Iwasaki K.  

Xenobiotica, Vol. 35, Iss. 6, 2005-06 ,pp. : 589-602

Informa Healthcare

Access to resources Recommend Favorite

Development of 3D-pharmacophore model followed by successive virtual screening, molecular docking and ADME studies for the design of potent CCR2 antagonists for inflammation-driven diseases

By Singh Rajesh   Balupuri Anand   Sobhia M. Elizabeth  

Molecular Simulation, Vol. 39, Iss. 1, 2013-01 ,pp. : 49-58

Taylor & Francis Ltd

Access to resources Recommend Favorite